INNEOVA Holdings Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data INNEOVA Holdings Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2022	FY2024	FY2024	FY2025
Revenue	51.4	62.7	62.7	58.4
Cost of revenue	42.2	50.7	50.4	47.2
Gross profit	9.28	12	12.3	11.2
Selling and marketing	1.69	1.45	1.69	1.17
General and administrative	5.98	7.1	8.7	9.29
Operating expenses	7.67	9.14	11.1	11.3
Operating income	1.61	2.86	1.25	-0.05
Interest expense	0.63	1.12	1.37	1.29
Other non-operating income	0.24	-0.71	-0.75	-1
Pre-tax income	1.85	2.15	0.5	-1.05
Income tax	0.33	0.29	0.13	-0.66
Net income	1.53	1.86	0.38	-0.4
EBITDA	1.81	3.45	1.91	0.77
EPS, basic	0.00	0.20	0.04	-0.03
EPS, diluted	0.00	0.20	0.04	-0.03
Shares, basic (weighted)	8.89	9.38	9.55	14.4
Shares, diluted (weighted)	8.89	9.38	9.55	14.4

Balance sheet

	FY2022	FY2024	FY2024	FY2025
Cash and equivalents		0.69	1.79	1.06
Receivables		14.6	13.2
Inventory		19	19.4	18.6
Other current assets		3.04	3.82	3.95
Total current assets		37.6	41.3	36.5
Property, plant and equipment		1.46	2.4	2.13
Lease right-of-use assets		0.63	0.67	0.66
Total assets	40.3	44.2	45.8	41.4
Accounts payable		4.65	4.92	5.05
Deferred revenue		3.9	5.4
Short-term debt		15.8	19.2	17.7
Total current liabilities		34.5	37	34.4
Lease liabilities		0.32	0.38	0.51
Total liabilities		36	40.9	36.4
Total debt		0.99	3.1	1.24
Paid-in capital		1.24	1.01	1.01
Retained earnings		1.81	4.89	4.49
Other comprehensive income		-0	-0.99	-0.54
Shareholders' equity	3.09	5.06	4.91	4.97
Total equity	3.09	5.06	4.91	4.97
Total liabilities and equity		39.1	45.8	41.4
Shares outstanding		9	10.3	16.5

Cash flow statement

	FY2022	FY2024	FY2024	FY2025
Net income	1.53	1.63	0.01	-0.4
Depreciation and amortization	0.2	0.6	0.66	0.82
Deferred income tax				-0.75
Change in receivables	-4.1	1.5	-0.45	3.19
Change in inventory	-3.52	-0.37	0.71	0.84
Change in payables	3.12	-0.28	0	0.37
Cash from operations	-2.06	3.74	2.53	4.44
Capital expenditures	-0.28	-0.31	-0.74	-0.01
Cash from investing	-0.28	-0.31	-0.74	-0.01
Cash from financing	2.14	-3.82	-0.63	-5.46
Net change in cash	-0.17	-0.27	0.97	-0.71
Free cash flow	-2.34	3.43	1.8	4.43
Interest paid	0.63	1.12	1.45	1.35
Income taxes paid	0.06	0.3	0.28	0.21

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.64 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	19.2%	Gross profit / revenue.
Operating margin	-0.1%	Operating income / revenue.
EBITDA margin	1.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-1.8%	Pre-tax income / revenue.
Net margin	-0.7%	Net income / revenue.
FCF margin	7.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.6%	Cash from operations / revenue.
Return on equity (ROE)	-8.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.9%	Net income / average total assets.
Return on invested capital (ROIC)	-0.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue	0.0%	Capital expenditures / revenue.
D&A / revenue	1.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-6.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	-8.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	-104.1%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-59.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-24.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-205.6%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-175.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	75.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	146.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	1.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	17.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-9.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	50.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	17.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.06x	Current assets / current liabilities.
Quick ratio	0.03x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.25x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	3.0%	Total debt / total assets.
Liabilities / assets	88.0%	Total liabilities / total assets.
Net debt	$182.0K	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-0.04x	Operating income / interest expense.
Working capital	$2.1M	Current assets - current liabilities.
Tangible book value	$5.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.34x	Revenue / average total assets.
Fixed asset turnover	25.8x	Revenue / average property, plant and equipment.
Inventory turnover	2.49x	Cost of revenue / average inventory.
Days inventory	147 days	365 x average inventory / cost of revenue.
Days payables	39 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	0.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$0.03	Net income per basic share, as reported (split-adjusted).
Revenue per share	$4.06	Revenue / diluted weighted shares.
FCF per share	$0.31	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.31	Cash from operations / diluted weighted shares.
Book value per share	$0.30	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.30	Tangible book value / shares outstanding.
Cash per share	$0.06	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$10.3M	Share price x shares outstanding.
Enterprise value	$10.5M	Market cap + total debt - cash - short-term investments.
P/S	0.18x	Market cap / revenue.
P/B	2.07x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.07x	Market cap / tangible book value, when positive.
P/FCF	2.32x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.31x	Market cap / cash from operations, when positive.
EV/Sales	0.18x	Enterprise value / revenue.
EV/EBITDA	13.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	2.36x	Enterprise value / free cash flow, when both are positive.
FCF yield	43.1%	Free cash flow / market cap.
Earnings yield	-3.9%	Net income / market cap (the inverse of P/E).

What was INNEOVA Holdings Ltd's revenue in fiscal 2025?

INNEOVA Holdings Ltd reported revenue of $58.4M for fiscal 2025, 6.9% lower than the year before.

Was INNEOVA Holdings Ltd profitable in fiscal 2025?

No. It reported a net loss of $397.0K.

How much free cash flow did INNEOVA Holdings Ltd generate in fiscal 2025?

Cash from operations of $4.4M minus capital expenditures of $10.0K left free cash flow of $4.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INNEOVA Holdings Ltd